Peering Into Moderna's Recent Short Interest
Portfolio Pulse from Benzinga Insights
Moderna's (NYSE:MRNA) short interest has increased by 10.47% since the last report, with 24.19 million shares sold short, representing 8.44% of available shares. It would take about 4.7 days to cover these short positions. While this rise in short interest could indicate bearish sentiment, it does not necessarily predict a near-term price drop. Moderna has a higher short interest than its peer group average of 5.36%.

January 17, 2024 | 7:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Moderna's increased short interest suggests bearish market sentiment, but it's not a clear indicator of an immediate price decline. The stock has more short interest compared to its peers.
While the increase in short interest for Moderna indicates that more traders are betting against the stock, it is not a definitive predictor of a price drop. The article suggests caution but does not imply an immediate impact on the stock price. The relevance is high as the news is directly about Moderna's stock, but the importance is moderate because short interest is just one of many factors that can affect stock prices. The confidence level is not at the maximum because market sentiment can be unpredictable and does not always correlate with immediate price movements.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 100